跳转至内容
Merck
CN
所有图片(2)

主要文件

查看所有文档

213942

Sigma-Aldrich

3-甲基胆蒽

98%

别名:

20-Methylcholanthrene, Methylcholanthrene

登录查看公司和协议定价
所有图片(2)

About This Item

经验公式（希尔记法）:
C21H16
CAS号:
56-49-5
分子量:
268.35
Beilstein:
1913890
EC 号:
200-276-4
MDL编号:
MFCD00003704
UNSPSC代码:
12352005
PubChem化学物质编号:
57647926
NACRES:
NA.25

质量水平

200

方案

98%

表单

solid

沸点

280 °C/80 mmHg (lit.)

mp

178-180 °C (lit.)

SMILES字符串

Cc1ccc2cc3c(ccc4ccccc34)c5CCc1c25

InChI

1S/C21H16/c1-13-6-7-15-12-20-17-5-3-2-4-14(17)8-9-18(20)19-11-10-16(13)21(15)19/h2-9,12H,10-11H2,1H3

InChI key

PPQNQXQZIWHJRB-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

应用

3-甲基胆蒽用于通过 Bhas 42细胞转化测定评估其肿瘤引发活性。也用来诱导细胞色素 P450 的活性。

生化/生理作用

3-甲基胆蒽是致癌物质，用于诱导培养细胞转化。也可用于诱发实验动物发生纤维肉瘤和皮肤癌。3-甲基胆蒽是芳香烃受体的强效激动剂。

象形图

Health hazard
GHS08

警示用语：

Danger

危险声明

H350,H413

预防措施声明

P201 - P273 - P308 + P313

危险分类

Aquatic Chronic 4 - Carc. 1B

储存分类代码

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

个人防护装备

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number
MKCW4323
MKCM7171
MKCG2810
MKBS1548V
MKBQ8665V

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Simple machine perfusion significantly enhances hepatocyte yields of ischemic and fresh rat livers
Izamis ML, et al.
Cell medicine, 4(3), 109-123 (2013)
Aryl Hydrocarbon Receptor: A New Player of Pathogenesis and Therapy in Cardiovascular Diseases
Yi T, et al.
BioMed Research International, 1-11 (2018)
A high-throughput Bhas 42 cell transformation assay for the determination of the carcinogenicity of three herbal extracts
Pu J, et al.
Fundamental Toxicological Sciences, 3(4), 157-166 (2016)
Nadine Y Crowe et al.
The Journal of experimental medicine, 196(1), 119-127 (2002-07-03)
Natural killer (NK) T cells initiate potent antitumor responses when stimulated by exogenous factors such as interleukin (IL)-12 or alpha-galactosylceramide (alpha-GalCer), however, it is not clear whether this reflects a physiological role for these cells in tumor immunity. Through adoptive
Michele W L Teng et al.
Cancer research, 72(16), 3987-3996 (2012-08-08)
Cancer immunoediting, the process by which the immune system controls tumor growth and shapes tumor immunogenicity, consists of 3 stages: elimination, equilibrium, and escape. The molecular mechanisms that underlie the equilibrium phase, during which the immune system maintains tumor dormancy
查看所有相关文献

商品

Carcinogenesis and Epigenetics

Cancer research has revealed that the classical model of carcinogenesis, a three step process consisting of initiation, promotion, and progression, is not complete.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门